Percutaneous Excision Trial

CompletedOBSERVATIONAL
Enrollment

1,170

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Imaged Breast Abnormalities
Trial Locations (24)

13790

Wilson Hospital Breast Center, Johnson City

13905

Lourdes Hospital Breast Center, Binghamton

15212

Allegheny General Hospital, Pittsburgh

17837

Evangelical Hospital, Lewisburg

21204

St. Joseph Medical Center, Towson

29576

Coastal Carolina Breast Center, Murrells Inlet

30058

Metro Surgical Associates, Inc., Lithonia

31793

TIFT Regionald Medical Center, Tifton

32086

Flagler Hospital, Saint Augustine

33407

Center for Breast Care HCA, West Palm Beach

37205

Nashville Breast Center, Nashville

44035

Elyria Memorial Hospital, Elyria

44145

St. John West Shore Hospital, Westlake

45236

Jewish Hospital Breast Center, Cincinnati

48439

Genesys Medical Center, Grand Blanc

64111

Saint Luke's Cancer Institute, Kansas City

66204

Shawnee Mission Medical Center, Overland Park

72205

University of Arkansas for Medical Services, Little Rock

90806

Long Beach Memorial Breast Center, Long Beach

91105

The Hill Breast Center, Pasadena

92201

The Breast Health Center, Indio

96793

Maui Medical Group, Wailuku

01102

Mercy Medical Center, Springfield

45267-0772

University of Cincinnati The Barrett Center, Cincinnati

Sponsors
All Listed Sponsors
lead

Intact Medical Corporation

INDUSTRY

NCT00720642 - Percutaneous Excision Trial | Biotech Hunter | Biotech Hunter